|
|
EUROs for $1 DOLLAR: 3 MONTHS |
 | |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings
11/15/2009 Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "BUY"for Warner Chilcott p (NASDAQ:WCRX) Stock.
WCRX stock opening price was $22.47 per share.
Current price of NASDAQ:WCRX Stock is $22.81 per share
and it is
$-0.11, (-0.48%) today
and it was trading in the daily range of $21.73 - 23.12 per share.
Current Bid Price for (NASDAQ:WCRX) stock is $22.01 and the Ask Price is $0.00. In the last 52 weeks
WCRX stock was trading in the range of $9.24 - 24.45. 50-Day Moving Average for (NASDAQ:WCRX) stock is
$22.4876 and 200-Day Moving Average is $16.8154. On average analysts predict that One Year Target Estimated price for
(NASDAQ:WCRX) stock is $26.50.
Warner Chilcott p (NASDAQ:WCRX) Market capitalization is $5.732B. (NASDAQ:WCRX) stock average daily volume is
1,885,850 shares per day.
However, on last trading session of Nov 13, 2009
WCRX stock traded 1,996,283 shares.
Also The Short Ratio for (NASDAQ:WCRX) stock is 5.60.
On previous trading session WCRX Stock closed at $22.92 per share.
Last year Warner Chilcott p (NASDAQ:WCRX) before taxes (EBITDA) (ttm) earned $536.0M on total revenue of $971.2M.
Earnings Per Share - EPS (ttm) for WCRX stock is 0.095.
Also, (NASDAQ:WCRX) Stock Price Per Earnings ratio - P/E is 241.26.
Thus, (NASDAQ:WCRX) Stock Price/Sales (ttm) ratio is 5.93 and Price/Book (mrq) ratio is 3.93.
(NASDAQ:WCRX) Stock does NOT PAY any dividend.
So at this time (NASDAQ:WCRX) Stock maintains Trailing Annual Dividend Rate at 0.00
.
StockRing Recommendations for Warner Chilcott p (NASDAQ:WCRX) Stock are updated daily here
http://www.StockRing.com/sr/StockDetail.asp?StockName=WCRX
If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com.
|
WCRX Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
| |
1 Year Dow Jones Chart |
1 Year S&P 500 Chart |
 |
 |
1 Year Nasdaq Chart |
1 Year Canada Chart |
 |
 |
|
| |
5 Days Dow Jones Chart |
5 Days S&P 500 Chart |
 |
 |
5 Days Nasdaq Chart |
5 Days Canada Chart |
 |
 |
|
WCRX Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
|
Last Trade: |
22.81 |
Trade Time: |
Nov 13 |
Change: |
-0.11, (-0.48%) |
Prev Close: |
22.92 |
Open: |
22.47 |
Bid: |
22.01 |
Ask: |
0.00 |
1y Target Est: |
$26.50 |
50-Day Moving Average: |
22.4876 |
200-Day Moving Average:
|
16.8154 |
Short Ratio: |
5.60 |
Trailing Annual Dividend Rate: |
0.00
|
|
Day's Range: |
21.73 - 23.12 |
52wk Range: |
9.24 - 24.45 |
Volume: |
1,996,283 |
Avg Vol: |
1,885,850 |
Market Cap: |
5.732B |
P/E (ttm): |
241.26 |
EPS (ttm): |
0.095 |
Div & Yield: |
0.00 (N/A%) |
Revenue (ttm): |
971.2M |
Earnings before Tax (EBITDA) (ttm): |
536.0M |
Price/Sales (ttm): |
5.93 |
Price/Book (mrq): |
3.93 |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
|
|
EUROs for $1 DOLLAR: 3 MONTHS |
 | |
|
Warner Chilcott plc (NasdaqGS: WCRX) Company Information
Warner Chilcott plc
Unit 19 Ardee Business Park
Hale Street
Ardee,
Ireland - Map
Phone: 353 41 685 6983
Web Site: http://www.warnerchilcott.com
Warner Chilcott plc (NasdaqGS: WCRX) DETAILS
Warner Chilcott plc (NasdaqGS: WCRX) Index Membership: Nasdaq 100
Warner Chilcott plc (NasdaqGS: WCRX) Sector: Healthcare
Warner Chilcott plc (NasdaqGS: WCRX) Industry: Drug Manufacturers - Other
Warner Chilcott plc (NasdaqGS: WCRX) Full Time Employees: 1,115
Warner Chilcott plc (NasdaqGS: WCRX) BUSINESS SUMMARY
Warner Chilcott Limited, a specialty pharmaceutical company, engages in the development, manufacture, marketing, and sale of branded prescription pharmaceutical products in women?s healthcare and dermatology segments primarily in the United States. The company offers various women healthcare products, including LOESTRIN 24 FE and FEMCON FE as oral contraceptives; FEMHRT 1/5 and .5/2.5 for oral treatment of moderate to severe vasomotor symptoms and urogenital symptoms associated with menopause; and ESTRACE cream to treat vaginal and vulvar atrophy. It also offers various dermatology products, such as TACLONEX and DOVONEX for the topical treatment of psoriasis; and DORYX, an oral adjunctive therapy for severe acne. In addition, its products under development include WC3016 and WC3026, the Phase III clinical trial completed products for low-dose oral contraceptive; WC2055, a Phase II clinical trials completed product for the treatment of acne; WC3018, a Phase II clinical trials product for the treatment of acne and other inflammatory skin conditions; LEO 80-185 for psoriasis of the scalp; and LEO 80-190, a Phase III clinical trial product for the treatment of psoriasis. Further, the company?s products under development comprise TD1414, a Phase II clinical trial product for skin infections; WC3027 for the treatment of inflammatory skin conditions; WC3035 for the treatment of acne and rosacea; and WC3036 and WC3043 for the treatment of erectile dysfunction. Warner Chilcott?s principal customers include wholesale pharmaceutical distributors, and retail drug and grocery store chains. It has license and supply agreement with LEO Pharma A/S. The company was founded in 1968 and is headquartered in Rockaway, New Jersey.
Warner Chilcott plc (NasdaqGS: WCRX) KEY EXECUTIVES, SALARIES and BONUSES
Mr. Roger M. Boissonneault , Age: 60
Chief Exec. Officer, Pres Salary: N/A Bonus: N/A
Mr. Paul Herendeen , Age: 53
Chief Financial Officer, Principal Accounting Officer and Exec. VP Salary: N/A Bonus: N/A
Mr. W. Carl Reichel , Age: 50
Pres of Pharmaceuticals Salary: N/A Bonus: N/A
Ms. Izumi Hara Esq., Age: 49
Sr. VP, Gen. Counsel and Corp. Sec. Salary: $ 424.00K Bonus: N/A
Mr. Anthony Bruno , Age: 53
Exec. VP of Corp. Devel. Salary: N/A Bonus: N/A
|
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Berkshire, BNI, ADBE, DDR, NNI, KWK, BBEP, WCRX, XOHO Popular Stocks
Ub News - Nov 9, 2009
US stocks traded higher Monday, with the Dow Jones Industrial Average rising 180 points to 10203, the S&P 500 up 21 points to 1090 and the Nasdaq Composite gaining 35 points to 2147. Berkshire ...
Is Bad News Good Again?
istockAnalyst.com - Nov 9, 2009
Good morning. Let's see a show of hands if you thought Friday's news that the Unemployment Rate jumped to 10.2% would wind up being a good thing for stocks. And no, you don't get to use hindsight ...
Market Report -- In Play (WCRX)
MSN Money - Nov 9, 2009
Warner Chilcott misses by $0.01, reports revs in-line Reports Q3 (Sep) earnings of $0.41 per share, ex-items, $0.01 worse than the First Call consensus of $0.42; revenues rose 9.0% year/year to ...
|
|
Berkshire, BNI, ADBE, DDR, NNI, KWK, BBEP, WCRX, XOHO Popular StocksUb News(NYSE:BNI, $97.37, +$0.14, 0.14%), posted a surge in third-quarter earnings, helped by a bounce in stock-index derivative contracts. ... |
|
|
No comments:
Post a Comment